DOCSLIB.ORG

The Pharmacologist 2 0 0 8 December

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Pharmacologist 2 0 0 8 December Vol. 50 Number 4 The Pharmacologist 2 0 0 8 December 2008: Year In Review ASPET Celebrates Presidential Torch Passed From 100th Anniversary President Minneman to President Beavo ASPET 100th Birthday Party in the Gaslamp District – San Diego ASPET Attends Clinical Pharmacology & Therapeutics - Quebec Award Winners in 2008 Also Inside this Issue: 2008 Contributors ASPET Election Nominees EB 2009 Program Grid Special Executive Officer Interview – Part IV SFN Mixer Pictures Abstracts from the MAPS Meeting A Publication of the American Society for 185 Pharmacology and Experimental Therapeutics - ASPET Volume 50 Number 4, 2008 The Pharmacologist is published and distributed by the American Society for Pharmacology and Experimental Therapeutics. The PHARMACOLOGIST Editor Suzie Thompson EDITORIAL ADVISORY BOARD News Suzanne G. Laychock, Ph.D. John S. Lazo, Ph.D. Terrence J. Monks, Ph.D. 2008 Year in Review . page 187 COUNCIL 2008 Contributors. page 188 President Joe A. Beavo, Ph.D. ASPET Election Nominees. page 190 President-Elect G-Protein Colloquium . page 193 Brian M. Cox, Ph.D. Past President EB 2009 Program Grid . page 194 Kenneth P. Minneman, Ph.D. Special Centennial Feature: The View From the Secretary/Treasurer Susan G. Amara, Ph.D. Executive Office . page 196 Secretary/Treasurer-Elect David R. Sibley, Ph.D. Past Secretary/Treasurer Features Annette E. Fleckenstein, Ph.D. Councilors Suzanne G. Laychock, Ph.D. Journals . page 203 John S. Lazo, Ph.D. Terrence J. Monks, Ph.D. Public Affairs & Government Relations . page 204 Chair, Board of Publications Trustees Division News . page 206 James E. Barrett, Ph.D. Chair, Program Committee Chapter News Jack Bergman, Ph.D. Abstracts from the MAPS Meeting . page 207 Chair, Long Range Planning Committee Elaine Sanders-Bush, Ph.D. Members in the News. page 223 Executive Officer Staff News . page 223 Christine K. Carrico, Ph.D. New ASPET Members . page 224 The Pharmacologist (ISSN 0031-7004) In Sympathy . page 227 is published quarterly in March, June, September, and December by the Obituary . American Society for Pharmacology and Experimental Therapeutics, 9650 Billy R. Martin . page 228 Rockville Pike, Bethesda, MD 20814- Norman J. Uretsky . page 229 3995. Annual subscription rates: $20.00 for ASPET Members; $45.00 for Edward J. Walaszek . page 230 U.S. nonmembers and institutions; $70.00 for nonmembers and institutions Announcements outside the U.S. Single copy: $20.00. Copyright © 2008 by the American Society for Pharmacology and Membership Information . page 235 Experimental Therapeutics, Inc. All rights reserved. Periodicals postage Membership Application . page 236 paid at Bethesda, MD. GST number for Canadian subscribers: BN:13489 2330 RT. ASPET assumes no responsibility for the statements and opinions advanced BE SURE PAY YOUR 2009 by contributors to The Pharmacologist. Deadlines for submission of material for MEMBERSHIP DUES BY publication: Issue 1, March 1; Issue 2, June 1; Issue 3, September 1; and Issue 4, December 1. JANUARY 1, 2009!! Postmaster: Send address changes to: The Pharmacologist, ASPET, 9650 Rockville Pike, Bethesda, MD 20814- 3995. A Publication of the American Society for 186 Pharmacology and Experimental Therapeutics - ASPET Volume 50 Number 4, 2008 YEAR IN REVIEW As 2008 comes to a close, ASPET would like to thank you for your participation in the Society and making our Centennial year the best year yet! With the help of member contributions, support and participation, we are pleased to announce the following accomplishments made by ASPET this year: Centennial Celebration: 2008 marked ASPET’s 100th Anniversary and we celebrated in a huge way! At this year’s Annual Meeting in San Diego, we threw a huge outdoor birthday party in the Gaslamp District. The street festival was attended by over 750 members, friends, and staff. The party was packed with live music, great food, drinks, and street entertainers, including a mime, a stilt-walker, and caricature artists. There was dancing, door prizes, and lots of fun. Outstanding science was also featured in our special Centennial symposia at the Annual Meeting. Topics included Cocaine Abuse, Schizophrenia, Obesity, and other hot topics in science. One special symposium featured ASPET’s Nobel Laureates, who shared their career experiences with students. We also commemorated our 100th Anniversary by creating a collection of interesting articles about ASPET and pharmacology. The Centennial Compendium was given to all ASPET members who attended our annual meeting. The compendium is now on sale online at www.aspet.org, along with other special Centennial memorabilia including, t-shirts, hats, and waterbottles. As part of our Centennial celebrations, we hosted a reception at the Clinical Pharmacology and Therapeutics meeting in Quebec this summer. ASPET was honored and recognized by CPT and IUPHAR for our achievements over the past 100 years. Awards: In 2008, we awarded 87 Graduate Student and 25 Young Scientist travel awards at the Experimental Biology meeting, all supported by member and corporate donations. In honor of our Centennial, we increased the number of travel awards this year. Membership: Our membership is growing, and 2008 proved to be another successful year in membership recruitment. This year, we have recruited close to 500 new members. Many ASPET members are taking an active role in recruiting their students, colleagues and friends into the Society. We hope to continue this growth and encourage greater interest in ASPET and pharmacology next year. As we wrap up this action packed year, we have many high hopes for 2009. ASPET is looking forward to expanding our membership base, reaching out to new members in new avenues. We are also working on updating our website to make it more user-friendly for our members. We expect another great Annual Meeting in New Orleans in April, and we hope that you will be a part of all our activities for 2009! Happy New Year! A Publication of the American Society for 187 Pharmacology and Experimental Therapeutics - ASPET Volume 50 Number 4, 2008 2008 CONTRIBUTORS ASPET gratefully acknowledges the following individuals who have made contributions over and above dues for 2008: Julius Axelrod Award Raymond M. Quock, PhD John F. Bowyer, PhD Fred Zeiger Marcus M. Reidenberg, MD Anthony J. Hance, PhD Richard M. Weinshilboum, MD David Dime, PhD Merle G. Paule, PhD Richard J. Wurtman, MD William W. Fleming, PhD Benedict R. Lucchesi Lectureshuip Solomon H. Synder, MD K.R. Hornbrook, PhD in Cardiac Pharmacology Phil Skolnick, PhD Richard L. Hauger, MD Garrett J. Gross, PhD George Kunos, MD, PhD Daniel B. Ellis, PhD Debra Diz, PhD Fulton Crews, PhD John H. Weisburger, PhD, FACN, MD Jinbao Huang Marc G. Caron, PhD Harold Boxenbaum, PhD Janice L. Stickney, PhD James P. O’Callaghan, PhD Burton M. Altura, PhD M.K. Shellenberger, PhD Kenneth M. Johnson, PhD Alan P. Poland, MD Benedict R. Lucchesi, MD, PhD John W. Daly, PhD Kyu-tae Kang, PhD Nancy J. Rusch, PhD S.S. Negus, PhD David J. Jones, PhD Kadhim N. Salman, PhD, Rph Elaine Sanders-Bush, PhD John R. Raymond, Sr., MD Larry R. Bush, PhD Patricia K. Sonsalla, PhD Karl H. Beyer Student Travel Award Christine K. Carrico, PhD Members Fund for Graduate Peter G. Dayton, DSc Student Travel Allen Barnett, PhD P.B. Dews Award Dorie W. Schwertz, PhD J. Fred Pritchard, PhD Victor G. Laties, PhD Robert N. Pechnick, PhD Annette Beyer-Mears, PhD Paul R. Draskoczy, MD Achilles J. Pappano, PhD Alexander Scriabine, MD Carol A. Paronis, PhD Elaine Sanders-Bush, PhD James W. McKearney, PhD B.B. Brodie Award Dale G. Hoyt, PhD Charles R. Schuster, PhD George D. Van Rossum, PhD Mitchell I. Steinberg, PhD Chris-Ellyn Johanson, PhD Gopal S. Rao, PhD Joe A. Beavo, PhD Jonathan L. Katz, PhD David Y. Cooper, MD Ingeborg Hanbauer, PhD Joseph M. Moerschbaecher, PhD Bettie Sue Masters, PhD K.R. Hornbrook, PhD Louis S. Harris, PhD H.G. Mandel, PhD Haian Fu, PhD James H. Woods, PhD Garold S. Yost, PhD John W. Regan, PhD Joseph G. Wettstein, PD Allan D. Blake, PhD Joseph P. Buckley Student Travel Robert F. Furchgott Student Travel Sakina E. Eltom, PhD, DVM Fund Fund Maria M. Salazar-Bookaman, PhD Douglas C. Eikenburg, PhD Suzanne G. Laychock, PhD Jerrold S. Meyer, PhD David E. Clarke, PhD Robert F. Furchgott, PhD Robin A. Dodson, PhD Balwant N. Dixit, PhD Diana N. Krause, PhD Michael J. Marks, PhD Mario D. Aceto, PhD Rosemary D. Bevan, BS, MB Patricia K. Sonsalla, PhD Philip C. Merker, PhD Eugene Roberts, PhD Joyce A. Goldstein, PhD Thomas F. Burks Student Travel Ronald P. Rubin, PhD Akira Tsuji, PhD Fund William L. West, PhD Alvin H. Gold, PhD Peter J. Davies, MD, PhD Philip C. Merker, PhD John J. Mieyal, PhD Joel G. Hardman, PhD Robert J. McIsaac, PhD Julio A. Copello, PhD Frank F. Vincenzi, PhD Odd S. Steinsland, PhD Abby C. Collier, PhD James V. Bruckner, PhD Stewart J. Ehrreich, PhD Gilandra K. Russell Konrad C. Miskowicz-Retz, PhD Stephanie W. Watts, PhD Ricardo A. Pena Kenneth D. Wild, PhD John R. Raymond, Sr. MD IUPHAR Travel Fund Robin A. Dodson, PhD Eric L. Barker, PhD Hirochika Komai, PhD Frank Porreca, PhD Thomas E. Donnelly, PhD Jogananda Hazra, PhD Kelvin W. Gee, PhD Margarita L. Dubocovich, PhD John P. Perkins Student Travel James J. Galligan, PhD Fund Paula Witt-Enderby, PhD Harvey B. Haag Student Travel Fund Joel G. Hardman, PhD Edward J. Bilsky, PhD Allan S. Yard, PhD Reginald W. Butcher, PhD Christine K. Carrico, PhD Keith F. & Eva K. Killam Student Rita J. Valentino, PhD David J. Jones, PhD Travel Fund David B. Bylund, PhD Centennial Fund David L. Nelson, PhD John R. Hepler, PhD John Parascandola, PhD Kelvin W. Gee, PhD Lee M. Graves, PhD Nancy R. Zahniser, PhD Anne K. Bonneville, PhD Richard B. Clark, PhD Glen R.
Load more

Recommended publications
  • You and AI Conversations About AI Technologies and Their Implications for Society
    You and AI Conversations about AI technologies and their implications for society SUPPORTED BY CONVERSATIONS ABOUT AI TECHNOLOGIES AND THEIR IMPLICATIONS FOR SOCIETY DeepMind1 2 CONVERSATIONS ABOUT AI TECHNOLOGIES AND THEIR IMPLICATIONS FOR SOCIETY You and AI Conversations about AI technologies and their implications for society Artificial Intelligence (AI) is the science of making computer systems smart, and an umbrella term for a range of technologies that carry out functions that typically require intelligence in humans. AI technologies already support many everyday products and services, and the power and reach of these technologies are advancing at pace. The Royal Society is working to support an environment of careful stewardship of AI technologies, so that their benefits can be brought into being safely and rapidly, and shared across society. In support of this aim, the Society’s You and AI series brought together leading AI researchers to contribute to a public conversation about advances in AI and their implications for society. CONVERSATIONS ABOUT AI TECHNOLOGIES AND THEIR IMPLICATIONS FOR SOCIETY 3 What AI can, and cannot, do The last decade has seen exciting developments in AI – and AI researchers are tackling some fundamental challenges to develop it further AI research seeks to understand what happens or inputs do not follow a standard intelligence is, and then recreate this through pattern, these systems cannot adapt their computer systems that can automatically rules or adjust their approach. perform tasks that require some level of reasoning or intelligence in humans. In the last decade, new methods that use learning algorithms have helped create In the past, AI research has concentrated computer systems that are more flexible on creating detailed rules for how to carry and adaptive, and Demis Hassabis FRS out a task and then developing computer (co-founder, DeepMind) has been at the systems that could carry out these rules; forefront of many of these developments.
    [Show full text]
  • The Pharmacologist 2 0 0 6 December
    Vol. 48 Number 4 The Pharmacologist 2 0 0 6 December 2006 YEAR IN REVIEW The Presidential Torch is passed from James E. Experimental Biology 2006 in San Francisco Barrett to Elaine Sanders-Bush ASPET Members attend the 15th World Congress in China Young Scientists at EB 2006 ASPET Awards Winners at EB 2006 Inside this Issue: ASPET Election Online EB ’07 Program Grid Neuropharmacology Division Mixer at SFN 2006 New England Chapter Meeting Summary SEPS Meeting Summary and Abstracts MAPS Meeting Summary and Abstracts Call for Late-Breaking Abstracts for EB‘07 A Publication of the American Society for 121 Pharmacology and Experimental Therapeutics - ASPET Volume 48 Number 4, 2006 The Pharmacologist is published and distributed by the American Society for Pharmacology and Experimental Therapeutics. The Editor PHARMACOLOGIST Suzie Thompson EDITORIAL ADVISORY BOARD Bryan F. Cox, Ph.D. News Ronald N. Hines, Ph.D. Terrence J. Monks, Ph.D. 2006 Year in Review page 123 COUNCIL . President Contributors for 2006 . page 124 Elaine Sanders-Bush, Ph.D. Election 2007 . President-Elect page 126 Kenneth P. Minneman, Ph.D. EB 2007 Program Grid . page 130 Past President James E. Barrett, Ph.D. Features Secretary/Treasurer Lynn Wecker, Ph.D. Secretary/Treasurer-Elect Journals . Annette E. Fleckenstein, Ph.D. page 132 Past Secretary/Treasurer Public Affairs & Government Relations . page 134 Patricia K. Sonsalla, Ph.D. Division News Councilors Bryan F. Cox, Ph.D. Division for Neuropharmacology . page 136 Ronald N. Hines, Ph.D. Centennial Update . Terrence J. Monks, Ph.D. page 137 Chair, Board of Publications Trustees Members in the News .
    [Show full text]
  • The Cosmos with Professor Brian
    The Cosmos with Professor Brian Cox Start time: 8pm Approximate running time: 90 minutes, no interval Please note all timings are approximate and subject to change Programme Jean Sibelius Symphony No 5, mv III (arr Iain Farrington) Charles Ives The Unanswered Question Gustav Mahler Symphony No 10, mv I (arr Michelle Castelletti) Emotion and angst is at the forefront of tonight’s BBC Symphony Orchestra programme, as Harriet Smith explains. Today’s concert, The Cosmos, is inspired by the idea from prominent physicist and broadcaster Brian Cox that music and science are interdependent ways in which we make sense of the world and universe around us. And he should know, for in his earlier days he was keyboard player in the prominent UK bands Dare and D:Ream. So what links tonight’s composers? On the one hand we have Jean Sibelius and Gustav Mahler – two of the most outstanding symphonists of the Romantic tradition – while on the other the American Charles Ives was to all intents and purposes an amateur, albeit a maverick genius. All three were influenced by what was around them in the wider world. In the case of the Finnish Sibelius, we’re lucky enough to have his diaries, which give a real clue into his mindset. While he was working on his Fifth Symphony, his diary of 21 April 1915, rhapsodises: ‘Today at ten to eleven, I saw sixteen swans. One of my greatest experiences! Lord God, what beauty! They circled over me for a long time. Disappeared into the solar haze like a gleaming, silver ribbon.
    [Show full text]
  • 1 TRP About Online
    a TR P to Spain International Workshop on Transient Receptor Potential Channels 12th – 14th September 2012 Valencia, Spain www.trp2012.com SCHEDULE and ABSTRACTS BOOK September 2012 Dear participants, Travelling to faraway places in search of spiritual or cultural enlightenment is a millennium old human activity. In their travels, pilgrims brought with them news, foods, music and traditions from distant lands. This friendly exchange led to the cultural enrichment of visitors and the economic flourishing of places, now iconic, such as Rome, Santiago, Jerusalem, Mecca, Varanasi or Angkor Thom. The dissemination of science and technology also benefited greatly from these travels to remote locations. The new pilgrims of the Transient Receptor Potential (TRP) community are also very fond of travelling. In the past years they have gathered at various locations around the globe: Breckenridge (USA), Eilat (Israel), Stockholm (Sweden) and Leuven (Belgium) come to mind. These meetings, each different and exciting, have been very important for the dissemination of TRP research. We are happy to welcome you in Valencia (Spain) for TRP2012. The response to our call has been extraordinary, surpassing all our expectations. The speakers, the modern bards, readily attended our request to communicate their new results. At last count we were already more than 170 participants, many of them students, and most presenting their recent work in the form of posters or short oral presentations. At least 25 countries are sending TRP ambassadors to Valencia, making this a truly international meeting. We like to thank the staff of the Cátedra Santiago Grisolía, Fundación Ciudad de las Artes y las Ciencias for their dedication and excellence in handling the administrative details of the workshop.
    [Show full text]
  • Therapeutic Targets for the Treatment of Chronic Cough
    Therapeutic Targets for the Treatment of Chronic Cough Roe, N., Lundy, F., Litherland, G. J., & McGarvey, L. (2019). Therapeutic Targets for the Treatment of Chronic Cough. Current Otorhinolaryngology Reports. https://doi.org/10.1007/s40136-019-00239-9 Published in: Current Otorhinolaryngology Reports Document Version: Publisher's PDF, also known as Version of record Queen's University Belfast - Research Portal: Link to publication record in Queen's University Belfast Research Portal Publisher rights Copyright 2019 the authors. This is an open access article published under a Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited. General rights Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the Research Portal that you believe breaches copyright or violates any law, please contact [email protected]. Download date:25. Sep. 2021 Current Otorhinolaryngology Reports https://doi.org/10.1007/s40136-019-00239-9 CHRONIC COUGH (K ALTMAN, SECTION EDITOR) Therapeutic Targets for the Treatment of Chronic Cough N.
    [Show full text]
  • Total Signatures
    VOICES FOR CARBON NEUTRALITY Petition Urging Immediate Action on U-M’s Commitment to Carbon Neutrality Faculty + Staff Signatories As of Tuesday, March 3, 2020 Total 1,423 Signatures 512 911 Michigan Medicine Other UM Schools 163 1,256 Students Non-Students 303 794 105 Staff Faculty GSI 79 138 Researchers Other Alex Kime Andy Kirshner Faculty Lecturer Amy Oakley Associate Professor Program on Intergroup Lecturer IV Performing Arts Technology/ A. Galip Ulsoy Relations (IGR) Molecular & Integrative Stamps Distinguished University Physiology Professor Emeritus Alexandra Paige Fischer Ana María León Angel Qin Mechanical Engineering Assistant Professor Assistant Professor Assistant Professor SEAS History of Art, RLL, Internal Medicine A. V. Szot Architecture LEO Intermittent Lecturer Alexandra Vinson Ania Aizman SEAS Assistant Professor Anastasia Hryhorczuk Assistant Professor and Department of Learning Assistant Clinical Professor Postdoctoral Fellow Aaron King Health Sciences of Radiology Slavic Languages and Nelson G. Hairston Literatures Collegiate Professor of Alice Telesnitsky Anatoli Lopatin Ecology, Evolutionary Professor Associate Professor Ann E.Larimore Biology, and Complex Microbiology and MIP Professor Emerita of Systems Immunology Geography and Women’s LSA-EEB, LSA-CSCS Anca Trandafirescu Studies Alison Tribble Associate Professor Residential College and Abigail Jacobs Clinical Assistant Professor Architecture Women’s Studiies Assistant Professor Pediatrics School of Information Andrea Franson Ann Little Allen Hsu Assistant Professor
    [Show full text]
  • Therapeutic Targets for the Treatment of Chronic Cough
    Current Otorhinolaryngology Reports https://doi.org/10.1007/s40136-019-00239-9 CHRONIC COUGH (K ALTMAN, SECTION EDITOR) Therapeutic Targets for the Treatment of Chronic Cough N. A. Roe1 & F. T. Lundy1 & G. J. Litherland2 & L. P. A. McGarvey1 # The Author(s) 2019 Abstract Purpose of Review Chronic cough, defined in adults as one lasting longer than 8 weeks, is among the commonest clinical problems encountered by doctors both in general practice and in hospital. It can exist as a distinct clinical problem or as a prominent and troublesome symptom for patients with common pulmonary conditions including asthma, chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Recent Findings Chronic cough impacts considerably on patients’ daily-life activities and many patients are left frustrated by what they see as a complete lack of awareness among their doctors as how to treat their condition. Some of this arises from limited levels of physician knowledge about managing cough as a clinical problem but also because there are no very effective treatments that specifically target cough. Summary In this article, we review the current clinical thinking regarding cough and the treatments that are currently used and those undergoing clinical development. Keywords Cough . Cough receptor . Pharmacological targets . Novel . Ion channel Introduction and is likely due to a slowly resolving post-viral cough. In adult patients, a cough persisting for more than 8 weeks is Under normal physiological circumstances, coughing occurs termed ‘chronic’ and can occur as an isolated clinical problem with the primary purpose of protecting the lung from inhaled or associated with common respiratory and non-respiratory irritants and clearing unwanted airway secretions.
    [Show full text]
  • The TRPV4 Agonist GSK1016790A Regulates the Membrane Expression of TRPV4 Channels
    ORIGINAL RESEARCH published: 23 January 2019 doi: 10.3389/fphar.2019.00006 The TRPV4 Agonist GSK1016790A Regulates the Membrane Expression of TRPV4 Channels Sara Baratchi 1*, Peter Keov 1,2,3, William G. Darby 1, Austin Lai 1, Khashayar Khoshmanesh 4, Peter Thurgood 4, Parisa Vahidi 1, Karin Ejendal 5 and Peter McIntyre 1 1 School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia, 2 Molecular Pharmacology Division, Victor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia, 3 St Vincent’s Clinical School, University of New South Wales, Darlinghurst, NSW, Australia, 4 School of Engineering, RMIT University, Melbourne, VIC, Australia, 5 Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN, United States TRPV4 is a non-selective cation channel that tunes the function of different tissues including the vascular endothelium, lung, chondrocytes, and neurons. GSK1016790A is the selective and potent agonist of TRPV4 and a pharmacological tool that is used to study the TRPV4 physiological function in vitro and in vivo. It remains unknown how the sensitivity of TRPV4 to this agonist is regulated. The spatial and temporal dynamics of receptors are the major determinants of cellular responses to stimuli. Membrane Edited by: Hugues Abriel, translocation has been shown to control the response of several members of the transient University of Bern, Switzerland receptor potential (TRP) family of ion channels to different stimuli. Here, we show that 2+ Reviewed by: TRPV4 stimulation with GSK1016790A caused an increase in [Ca ]i that is stable for Osama F. Harraz, a few minutes. Single molecule analysis of TRPV4 channels showed that the density University of Vermont, United States Irene Frischauf, of TRPV4 at the plasma membrane is controlled through two modes of membrane Johannes Kepler University of Linz, trafficking, complete, and partial vesicular fusion.
    [Show full text]
  • Note: the Letters 'F' and 'T' Following the Locators Refers to Figures and Tables
    Index Note: The letters ‘f’ and ‘t’ following the locators refers to figures and tables cited in the text. A Acyl-lipid desaturas, 455 AA, see Arachidonic acid (AA) Adenophostin A, 71, 72t aa, see Amino acid (aa) Adenosine 5-diphosphoribose, 65, 789 AACOCF3, see Arachidonyl trifluoromethyl Adlea, 651 ketone (AACOCF3) ADP, 4t, 10, 155, 597, 598f, 599, 602, 669, α1A-adrenoceptor antagonist prazosin, 711t, 814–815, 890 553 ADPKD, see Autosomal dominant polycystic aa 723–928 fragment, 19 kidney disease (ADPKD) aa 839–873 fragment, 17, 19 ADPKD-causing mutations Aβ, see Amyloid β-peptide (Aβ) PKD1 ABC protein, see ATP-binding cassette protein L4224P, 17 (ABC transporter) R4227X, 17 Abeele, F. V., 715 TRPP2 Abbott Laboratories, 645 E837X, 17 ACA, see N-(p-amylcinnamoyl)anthranilic R742X, 17 acid (ACA) R807X, 17 Acetaldehyde, 68t, 69 R872X, 17 Acetic acid-induced nociceptive response, ADPR, see ADP-ribose (ADPR) 50 ADP-ribose (ADPR), 99, 112–113, 113f, Acetylcholine-secreting sympathetic neuron, 380–382, 464, 534–536, 535f, 179 537f, 538, 711t, 712–713, Acetylsalicylic acid, 49t, 55 717, 770, 784, 789, 816–820, Acrolein, 67t, 69, 867, 971–972 885 Acrosome reaction, 125, 130, 301, 325, β-Adrenergic agonists, 740 578, 881–882, 885, 888–889, α2 Adrenoreceptor, 49t, 55, 188 891–895 Adult polycystic kidney disease (ADPKD), Actinopterigy, 223 1023 Activation gate, 485–486 Aframomum daniellii (aframodial), 46t, 52 Leu681, amino acid residue, 485–486 Aframomum melegueta (Melegueta pepper), Tyr671, ion pathway, 486 45t, 51, 70 Acute myeloid leukaemia and myelodysplastic Agelenopsis aperta (American funnel web syndrome (AML/MDS), 949 spider), 48t, 54 Acylated phloroglucinol hyperforin, 71 Agonist-dependent vasorelaxation, 378 Acylation, 96 Ahern, G.
    [Show full text]
  • Transient Receptor Potential Vanilloid 4 Channel Deficiency Aggravates Tubular Damage After Acute Renal Ischaemia Reperfusion
    www.nature.com/scientificreports OPEN Transient Receptor Potential Vanilloid 4 Channel Defciency Aggravates Tubular Damage after Received: 29 March 2017 Accepted: 5 March 2018 Acute Renal Ischaemia Reperfusion Published: xx xx xxxx Marwan Mannaa1, Lajos Markó2, András Balogh2,3,4, Emilia Vigolo5, Gabriele N’diaye2, Mario Kaßmann1, Laura Michalick6, Ulrike Weichelt6, Kai M. Schmidt–Ott5, Wolfgang B. Liedtke7, Yu Huang8,9, Dominik N. Müller 2,5, Wolfgang M. Kuebler6 & Maik Gollasch1,2 Transient receptor potential vanilloid 4 (TRPV4) cation channels are functional in all renal vascular segments and mediate endothelium-dependent vasorelaxation. Moreover, they are expressed in distinct parts of the tubular system and activated by cell swelling. Ischaemia/reperfusion injury (IRI) is characterized by tubular injury and endothelial dysfunction. Therefore, we hypothesised a putative organ protective role of TRPV4 in acute renal IRI. IRI was induced in TRPV4 defcient (Trpv4 KO) and wild–type (WT) control mice by clipping the left renal pedicle after right–sided nephrectomy. Serum creatinine level was higher in Trpv4 KO mice 6 and 24 hours after ischaemia compared to WT mice. Detailed histological analysis revealed that IRI caused aggravated renal tubular damage in Trpv4 KO mice, especially in the renal cortex. Immunohistological and functional assessment confrmed TRPV4 expression in proximal tubular cells. Furthermore, the tubular damage could be attributed to enhanced necrosis rather than apoptosis. Surprisingly, the percentage of infltrating granulocytes and macrophages were comparable in IRI–damaged kidneys of Trpv4 KO and WT mice. The present results suggest a renoprotective role of TRPV4 during acute renal IRI. Further studies using cell–specifc TRPV4 defcient mice are needed to clarify cellular mechanisms of TRPV4 in IRI.
    [Show full text]
  • TRP CHANNELS AS THERAPEUTIC TARGETS TRP CHANNELS AS THERAPEUTIC TARGETS from Basic Science to Clinical Use
    TRP CHANNELS AS THERAPEUTIC TARGETS TRP CHANNELS AS THERAPEUTIC TARGETS From Basic Science to Clinical Use Edited by ARPAD SZALLASI MD, PHD Department of Pathology, Monmouth Medical Center, Long Branch, NJ, USA AMSTERDAM • BOSTON • HEIDELBERG • LONDON NEW YORK • OXFORD • PARIS • SAN DIEGO SAN FRANCISCO • SINGAPORE • SYDNEY • TOKYO Academic Press is an imprint of Elsevier Academic Press is an imprint of Elsevier 125 London Wall, London, EC2Y 5AS, UK 525 B Street, Suite 1800, San Diego, CA 92101-4495, USA 225 Wyman Street, Waltham, MA 02451, USA The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, UK First published 2015 Copyright © 2015 Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval system, without permission in writing from the publisher. Details on how to seek permission, further information about the Publisher’s permissions policies and our arrangement with organizations such as the Copyright Clearance Center and the Copyright Licensing Agency, can be found at our website: www.elsevier.com/permissions This book and the individual contributions contained in it are protected under copyright by the Publisher (other than as may be noted herein). Notices Knowledge and best practice in this field are constantly changing. As new research and experience broaden our understanding, changes in research methods, professional practices, or medical treatment may become necessary. Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any information, methods, compounds, or experiments described herein.
    [Show full text]
  • Application Note Activation and Inhibition of TRPV4 Using Different
    Channel: hTRPV4 Application Note Cells: CHO Tools: Port-a-Patch Activation and inhibition of TRPV4 using different stimuli on the Port-a-Patch The electrophysiology team at Nanion Technologies GmbH, Munich. Summary Results TRPV4 is a member of the transient receptor potential TRPV4 can be activated by a number of stimuli, includ- channel (TRP) family. Transient receptor potential vanilloid ing warm temperature >27°C6,7. We activated hTRPV4 type 4 (TRPV4) shares approximately 40% identity with expressed in CHO cells using heated solution at 45°C. TRPV1 and TRPV21 and is a Ca2+-permeable non-selective There was some basal activity of TRPV4 at room tempera- cation channel1-3 expressed in a wide range of tissues ture but the current amplitude increased to 5.7 ± 0.8 nA including neurons of the central and peripheral nervous (n = 6) from control current of 2.7 ± 0.6 nM (n = 6; p<0.01, systems, and in non-neuronal tissue including human T Student’s t test). Figure 1 shows the activation of TRPV4 by cells, corneal and retinal epithelial cells, endothelial cells warm solution from an example cell and the timecourse of the eye, liver, heart, kidney, synoviocytes, epithelial of the experiment. lining of trachea and lung airways, stellate cells of the A RT pancreas, and many more2. TRPV4 is activated by a 45°C number of stimuli including endogenous ligands such as lipid arachidonic acid and its metabolites4, synthetic ligands such as GSK1016790A5, warm temperature >27- 35°C6,7, hypotonic extracellular solution (cell swelling)1,8, and mechanical stress2. Given its widespread distribution in many organs, this suggests that TRPV4 plays a major role in many physiological processes2,9.
    [Show full text]